Aeternum Health Inc. (AETN)
OTCMKTS · Delayed Price · Currency is USD
0.1270
0.00 (0.00%)
At close: Jul 23, 2026
Aeternum Health Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2024 | FY 2023 | FY 2023 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Feb '24 Feb 29, 2024 | Dec '23 Dec 31, 2023 | Feb '23 Feb 28, 2023 |
Cash & Equivalents | 0.02 | 0.02 | 0.02 | 0.18 | 0.29 | 0.11 |
Cash & Short-Term Investments | 0.02 | 0.02 | 0.02 | 0.18 | 0.29 | 0.11 |
Cash Growth | - | -16.14% | -89.65% | -38.00% | 148.69% | 1711.24% |
Accounts Receivable | 0 | 0 | - | - | - | - |
Receivables | 0 | 0 | - | 0.02 | 0.02 | - |
Inventory | 0.04 | 0.04 | 0.04 | 0.01 | 0.01 | 0.01 |
Prepaid Expenses | - | - | 0 | 0.01 | - | 0 |
Other Current Assets | - | - | - | - | - | 0.55 |
Total Current Assets | 0.06 | 0.05 | 0.06 | 0.21 | 0.31 | 0.68 |
Other Intangible Assets | 0.02 | - | - | - | - | - |
Other Long-Term Assets | 0 | 0 | 0 | 0 | 0 | 0 |
Total Assets | 0.08 | 0.05 | 0.07 | 0.21 | 0.31 | 0.68 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2024 | FY 2023 | FY 2023 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Feb '24 Feb 29, 2024 | Dec '23 Dec 31, 2023 | Feb '23 Feb 28, 2023 |
Accounts Payable | 0.14 | 0.13 | 0.09 | 0.05 | 0.02 | 0.11 |
Accrued Expenses | 0.84 | 0.77 | 0.49 | 0.23 | 0.24 | 0.03 |
Short-Term Debt | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 |
Current Portion of Long-Term Debt | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.11 |
Total Current Liabilities | 1.22 | 1.13 | 0.82 | 0.52 | 0.5 | 0.36 |
Long-Term Debt | 0.92 | 0.92 | 0.92 | 1 | 1.03 | 1.16 |
Total Liabilities | 2.14 | 2.05 | 1.74 | 1.52 | 1.53 | 1.52 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2024 | FY 2023 | FY 2023 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Feb '24 Feb 29, 2024 | Dec '23 Dec 31, 2023 | Feb '23 Feb 28, 2023 |
Common Stock | 0.52 | 0.49 | 0.48 | 0.48 | 0.48 | 0.47 |
Additional Paid-In Capital | 0.86 | 0.81 | 0.8 | 0.8 | 0.8 | 0.62 |
Retained Earnings | -3.42 | -3.28 | -2.94 | -2.58 | -2.49 | -1.91 |
Treasury Stock | -0.04 | -0.04 | -0.04 | -0.04 | -0.04 | -0.04 |
Total Common Equity | -2.08 | -2.02 | -1.7 | -1.33 | -1.25 | -0.87 |
Shareholders' Equity | -2.06 | -2 | -1.68 | -1.31 | -1.23 | -0.85 |
Total Liabilities & Equity | 0.08 | 0.05 | 0.07 | 0.21 | 0.31 | 0.68 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2024 | FY 2023 | FY 2023 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Feb '24 Feb 29, 2024 | Dec '23 Dec 31, 2023 | Feb '23 Feb 28, 2023 |
Total Debt | 1.16 | 1.16 | 1.16 | 1.23 | 1.27 | 1.38 |
Net Cash (Debt) | -1.14 | -1.14 | -1.14 | -1.06 | -0.98 | -1.27 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.03 |
Filing Date Shares Outstanding | 52.15 | 52.19 | 49.19 | 48.48 | 24.49 | 161.44 |
Total Common Shares Outstanding | 52.15 | 49.15 | 48.44 | 48.48 | 24.49 | 161.44 |
Working Capital | -1.16 | -1.08 | -0.76 | -0.32 | -0.19 | 0.32 |
Book Value Per Share | -0.04 | -0.04 | -0.04 | -0.03 | -0.05 | -0.01 |
Tangible Book Value | -2.1 | -2.02 | -1.7 | -1.33 | -1.25 | -0.87 |
Tangible Book Value Per Share | -0.04 | -0.04 | -0.04 | -0.03 | -0.05 | -0.01 |